Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 12/2015

01.12.2015 | Original Paper

HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling

verfasst von: Alexander R. Bazazi, Forrest Crawford, Alexei Zelenev, Robert Heimer, Adeeba Kamarulzaman, Frederick L. Altice

Erschienen in: AIDS and Behavior | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

The HIV epidemic in Malaysia is concentrated among people who inject drugs (PWID). Accurate estimates of HIV prevalence are critical for developing appropriate treatment and prevention interventions for PWID in Malaysia. In 2010, 461 PWID were recruited using respondent-driven sampling in Greater Kuala Lumpur, Malaysia. Participants completed rapid HIV testing and behavioral assessments. Estimates of HIV prevalence were computed for each of the three recruitment sites and the overall sample. HIV prevalence was 15.8 % (95 % CI 12.5–19.2 %) overall but varied widely by location: 37.0 % (28.6–45.4 %) in Kampung Baru, 10.3 % (5.0–15.6 %) in Kajang, and 6.3 % (3.0–9.5 %) in Shah Alam. Recruitment extended to locations far from initial interview sites but was concentrated around discrete geographic regions. We document the high prevalence of HIV among PWID in Greater Kuala Lumpur. Sustained support for community surveillance and HIV prevention interventions is needed to stem the HIV epidemic among PWID in Malaysia.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Malaysia Country Responses to HIV/AIDS. Reporting period: January 2013–December 2013: AIDS/STD Section, Diseases Control Division, Ministry of Health, Government of Malaysia. 2014.
2.
Kamarulzaman A. Impact of HIV prevention programs on drug users in Malaysia. JAIDS J Acquir Immune Defic Syndr. 2009;52:S17–9.CrossRefPubMed
3.
Malaysian AIDS Council, Malaysian AIDS Foundation. 2013 Annual Report. 2014.
4.
Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A. Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLoS One. 2012;7(9):e44249.PubMedCentralCrossRefPubMed
5.
Degenhardt L, Mathers BM, Wirtz AL, et al. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010–2012? A review of the six highest burden countries. Int J Drug Policy. 2014;25(1):53–60.CrossRefPubMed
6.
Ghani MA, Brown SE, Khan F, et al. An exploratory qualitative assessment of self-reported treatment outcomes and satisfaction among patients accessing an innovative voluntary drug treatment centre in Malaysia. Int J Drug Policy. 2015;26(2):175–82.CrossRefPubMed
7.
Jin H, Earnshaw VA, Wickersham JA, et al. An assessment of health-care students’ attitudes toward patients with or at high risk for HIV: implications for education and cultural competency. AIDS Care. 2014;26(10):1223–8.PubMedCentralCrossRefPubMed
8.
Act 234: Dangerous drugs act 1952, revised. 2006.
9.
Act 283: Drug dependents (Treatment and rehabilitations) act 1983, revised. 2006.
10.
Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44:174–99.CrossRef
11.
Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol. 2004;34(1):193–240.CrossRef
12.
13.
Malekinejad M, Johnston LG, Kendall C, Kerr LRFS, Rifkin MR, Rutherford GW. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008;12(1):105–30.CrossRef
14.
Centers for Disease Control and Prevention. HIV infection and HIV-associated behaviors among injecting drug users-20 cities, United States, 2009. MMWR. 2012;61(8):133.
15.
World Health Organization. Introduction to HIV, AIDS and sexually transmitted infection surveillance. UNAIDS: World Health Organization; 2010.
16.
Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49(1):11–34.CrossRef
17.
Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Off Stat. 2008;24(1):79–97.
18.
Gile KJ, Handcock MS. Network model-assisted inference from respondent-driven sampling data. arXiv preprint arXiv:1108.0298. 2011.
19.
Heimer R. Critical issues and further questions about respondent-driven sampling: comment on Ramirez-Valles, et al. (2005). AIDS Behav. 2005;9(4):403–8.CrossRefPubMed
20.
21.
22.
Salganik MJ. Commentary: respondent-driven sampling in the real world. Epidemiology. 2012;23(1):148–50.CrossRefPubMed
23.
24.
Crawford FW. The graphical structure of respondent-driven sampling. arXiv:1406.0721. 2014.
25.
Gile KJ, Johnston LG, Salganik MJ. Diagnostics for respondent-driven sampling. J R Stat Soc. 2015;178(1):241–69.CrossRef
26.
Salganik MJ. Variance estimation, design effects, and sample size calculations for respondent-driven sampling. J Urban Health. 2006;83(1):98–112.PubMedCentralCrossRef
27.
McCarty C, Killworth PD, Bernard RH, Johnsen EC, Shelley GA. Comparing two methods for estimating network size. Hum Organ. 2001;60(1):28–39.CrossRef
28.
Sheehan DV, Lecrubier Y, Sheehan KH, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(20):22–33;quiz 34–57.PubMed
29.
30.
31.
Gile KJ. Improved inference for respondent-driven sampling data with application to HIV prevalence estimation. J Am Stat Assoc. 2011;106(493):135–46.CrossRef
32.
33.
Wejnert C. An empirical test of respondent-driven sampling: point estimates, variance, degree measures, and out-of-equilibrium data. Sociol Methodol. 2009;39(1):73–116.PubMedCentralCrossRefPubMed
34.
Gabor C, Nepusz T. The igraph software package for complex network research. Int J Complex Syst. 2006.
35.
Bazazi AR, Zelenev A, Fu JJ, Yee I, Kamarulzaman A, Altice FL. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: correlates of overdose and implications for overdose prevention from a cross-sectional study. Int J Drug Policy. 2014.
36.
Vijay A, Bazazi AR, Yee I, Kamarulzaman A, Altice FL. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. J Subst Abus Treat. 2015;54:29–36.CrossRef
37.
Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.CrossRefPubMed
38.
Singh S, Crofts N. HIV infection among injecting drug users in north-east Malaysia, 1992. AIDS Care. 1993;5(3):273–81.CrossRefPubMed
39.
Vicknasingam B, Narayanan S, Navaratnam V. The relative risk of HIV among IDUs not in treatment in Malaysia. AIDS Care. 2009;21(8):984–91.CrossRefPubMed
40.
De P, Cox J, Boivin JF, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction. 2007;102(11):1730–9.CrossRefPubMed
41.
Costenbader EC, Astone NM, Latkin CA. The dynamics of injection drug users’ personal networks and HIV risk behaviors. Addiction. 2006;101(7):1003–13.CrossRefPubMed
42.
Hoffmann JP, Su SS, Pach A. Changes in network characteristics and HIV risk behavior among injection drug users. Drug Alcohol Depend. 1997;46(1–2):41–51.CrossRefPubMed
43.
Rudolph AE, Fuller CM, Latkin C. The importance of measuring and accounting for potential biases in respondent-driven samples. AIDS Behav. 2013;17(6):2244–52.PubMedCentralCrossRefPubMed
44.
Vickerman P, Platt L, Jolley E, Rhodes T, Kazatchkine MD, Latypov A. Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modelling. Int J Drug Policy. 2014;25(6):1163–73.CrossRefPubMed
45.
Toledo L, Codeco CT, Bertoni N, et al. Putting respondent-driven sampling on the map: insights from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 2011;57(3):S136–43.CrossRefPubMed
46.
McCreesh N, Johnston LG, Copas A, et al. Evaluation of the role of location and distance in recruitment in respondent-driven sampling. Int J Health Geogr. 2011;10(1):56.PubMedCentralCrossRefPubMed
47.
Young AM, Rudolph AE, Quillen D, Havens JR. Spatial, temporal and relational patterns in respondent-driven sampling: evidence from a social network study of rural drug users. J Epidemiol Community Health. 2014;68(8):792–8.PubMedCentralCrossRefPubMed
48.
Qiu P, Yang Y, Ma X, et al. Respondent-driven sampling to recruit in-country migrant workers in China: a methodological assessment. Scand J Public Health. 2012;40(1):92–101.CrossRefPubMed
49.
Springer SA, Larney S, Mehrjerdi ZA, Metzger D, Altice FL, Shoptaw S. Drug treatment as HIV prevention among women and girls who use drugs from a global perspective: progress, gaps and future directions. J Acquir Immune Defic Syndr. 2015 (In press).
50.
51.
Wickersham JA, Loeliger K, Marcus R, Pillai V, Kamarulzaman A, Altice FL. Correlates of lifetime and active injection drug use among women in Malaysia. Am J Drug Alcohol Abus. 2015 (In press).
52.
Department of Statistics Malaysia. 2010 Population and housing census of Malaysia: population distribution and basic demographic characteristics. 2011.
53.
Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention. Drug Alcohol Depend. 2011;116(1–3):151–7.PubMedCentralCrossRefPubMed
Metadaten
Titel
HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling
verfasst von
Alexander R. Bazazi
Forrest Crawford
Alexei Zelenev
Robert Heimer
Adeeba Kamarulzaman
Frederick L. Altice
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 12/2015
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-015-1191-y

Weitere Artikel der Ausgabe 12/2015

AIDS and Behavior 12/2015 Zur Ausgabe

Original Paper

Correlates of Seroadaptation Strategies Among Black Men Who have Sex with Men (MSM) in 4 US Cities

Original Paper

Understanding Gay Community Subcultures: Implications for HIV Prevention

Brief Report

Transactional Sex and the HIV Epidemic Among Men Who have Sex with Men (MSM): Results From a Systematic Review and Meta-analysis

Original Paper

Willingness to Take PrEP and Potential for Risk Compensation Among Highly Sexually Active Gay and Bisexual Men

Original Paper

Attitudes Towards Power in Relationships and Sexual Concurrency Within Heterosexual Youth Partnerships in Baltimore, MD

Original Paper

Social Cognition Variables and Victimization as Predictors of Sexual Debut Among Adolescents in South Africa and Tanzania: A Multi-group SEM Analysis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise